Patent Assignment
Reel/Frame 030167/0733
Assignment of Assignor's Interest
Recorded: 2013-04-08
Pages: 9
Assignor
ABBOTT LABORATORIES
Executed: 2012-08-01
Assignee
ABBVIE INC.
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, ILLINOIS, 60064
Covered Properties
(71)
Neuromuscular Blocking Agents
Patent:
5,556,978 →
Application:
08/413,217 →
Automated Sample Handling for X-Ray Crystallography
6-0-Methylerythromycin a Crystal Form Iii
Patent:
6,627,743 →
Application:
09/454,366 →
Antisense oligonucleotides of the human chk1 gene and uses thereof
Patent:
6,211,164 →
Application:
09/522,800 →
Process for the preparation of midazolam
Patent:
6,262,260 →
Application:
09/533,160 →
Process for the Preparation of 6-0-Propargyl Erthromycin Derivatives
Patent:
6,605,707 →
Application:
09/533,703 →
Synthetic method for the fluoromethylation of alcohols
Patent:
6,245,949 →
Application:
09/587,414 →
Method for fluoromethylation of alcohols via halogenative decarboxylation
Patent:
6,271,422 →
Application:
09/587,417 →
Synthetic method for fluoromethylation of halogenated alcohols
Patent:
6,303,831 →
Application:
09/587,421 →
9A-Azalides with Antibacterial Activity
Patent:
6,764,996 →
Application:
09/624,849 →
3-substituted indole angiogenesis inhibitors
Patent:
6,323,228 →
Application:
09/663,005 →
N-Alkylated Peptides Having Antiangiogenic Activity
Patent:
6,777,535 →
Application:
09/703,233 →
Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications
Patent:
6,316,475 →
Application:
09/715,601 →
Mutant Bcl-2 Proteins and Uses Thereof
Patent:
7,226,992 →
Application:
09/716,395 →
Peptides Having Antiangiogenic Activity
Patent:
6,753,408 →
Application:
09/718,591 →
6-O-Alkyl-2-Nor-2-Substituted Ketolide Derivatives
Methods Utilizing Aryl Thioimines in Synthesis of Erythromycin Derivatives
Substituted Pyridine Compounds Useful for Controlling Chemical Synaptic Transmission
Apparatus and Method for Electophysiological Testing
Anti-Infective Agents Useful Against Multidrug-Resistant Strains of Bacteria
Crystalline Pharmaceutical
Cyclic and Bicyclic Diamino Histamine-3 Receptor Antagonists
Diazabicyclic Central Nervous System Active Agents
Naphthamidine Urokinase Inhibitors
Patent:
6,495,562 →
Application:
09/842,382 →
1,3-Disubstituted and 1,3,3-Trisubstituted Pyrrolidines as Histamine-3 Receptor Ligands and Their Therapeutic Applications
Method for Controling the Proportion of Fluid Passing Through a Filter
Amino(Oxo) Acetic Acid Protein Tyrosine Phosphatase Inhibitors
Protein Tyrosine Phosphatase Inhibitors
Selective Protein Tyrosine Phosphatatase Inhibitors
Processes and intermediates for preparing retroviral protease inhibitors
Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions
Process for the Preparation of Cell Proliferation Inhibitors
N-Acylsulfonamide Apoptosis Promoters
Process for the Preparation of 5-(Substituted)-10-Methoxy-2,2,4-Trimethyl-2,5-Dihydro-1H-Chromeno[3,4-F]Quinolines and Derivatives Thereof
Patent:
6,518,430 →
Application:
09/960,205 →
Farnesyltransferase Inhibitors
Alkynyl Amides and Their Therapeutic Applications
Concentrated Spent Fermentation Beer of Saccharopolyspora Erythraea Activated by an Enzyme Mixture as a Nutitional Feed Supplement
Use of Tiagabine for Treatment of Diabetic Neuropathy and Migraine
1,3-Disubstituted and 1,3,3-Trisubstituted Pyrrolidines as Histamine-3 Receptor Ligands and Their Therapeutic Applications
9-Amino Erythromycin Derivatives with Antibacterial Activity
Novel Amines as Histamine-3 Receptor Ligands and Their Therapeutic Applications
Benzimidazoles That Are Useful in Treating Sexual Dysfunction
Trisubstituted-N-[(1S)-1,2,3,4-Terrahydro-1-Naphthalenyl]Benzamides Which Inhibit P2X2/3 Containing Receptors
Arylation Method for the Functionalization of O-Allyl Erythromycin Derivatives
Benzimidazoles That Are Useful in Treating Sexual Dysfunction
Tetra-, Penta-, Hexa- and Heptapeptides Having Antiangiogenic Activity
Hepta-, Octa-and Nonapeptides Having Antiangiogenic Activity
Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity
Tri-, Tetra-, and Penta-Peptides Having Antiangiogenic Activity
Di-, Tri-, and Tetra-Peptides Having Antiangiogenic Activity
Process for the Preparation of 5-(Substituted)-10 Methoxy-2,2,4-Trimethyl-2,5-Dihydro- 1H-Chromeno [3,4-F] Quinolines and Derivatives Thereof
Protein Kinase Inhibitors
Kinase Inhibitors
Macrolide Antibacterial Compounds
Crystalline Pharmaceutical
Benzimidazoles That Are Useful in Treating Sexual Dysfunction
Hydrazide and Alkoxyamide Angiogenesis Inhibitors
Diazabicyclic Central Nervous System Active Agents
N-Acylsulfonamide Apoptosis Promoters
Fused Azabicycic Compounds That Inhibit Vanilloid Receptor Subtype 1(VR1) Receptor
Method for the Preparation of Fluticasone and Related 17BETA-Carbothioic Esters Using a Novel Carbothioic Acid Synthesis and Novel Purification Methods
Novel Amines as Histamine-3 Receptor Ligands and Their Therapeutic Applications
Farnesyltransferase Inhibitors
Use of selective dopamine D4 receptor agonists for treating sexual dysfunction
Application:
11/504,342 →
Publication:
US 2006/0276484
Crystalline Pharmaceutical
Diazabicyclic Central Nervous System Active Agents
Fused Azabicyclic Compounds That Inhibit Vanilloid Receptor Subtype 1 (VR1) Receptor
N-Acylsulfonamide Apoptosis Promoters
Diazabicyclic Central Nervous System Active Agents
Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions
Crystalline Pharmaceutical
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.